Tandospirone citrate

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C21H29N5O2.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0R8E9BWM4J, chemically known as 4,7-methano-1h-isoindole-1,3(2h)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) but more generally known as tandospirone citrate, which bears US NIH Compound Identifier 60558. European Medicines Agency schedules Tandospirone citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04674MIG. Most nations, for tariff and trade purposes, schedule tandospirone citrate under HS 29335995. As of Q4 2014, TANDOSPIRONE CITRATE remains US FDA's Preferred Term for this commodity. Tandospirone citrate bears US NLM identifiers UMLS ID C2699890 and NCI Concept Code C74390. SMILES: C1CNC(NC1)N2CCN(CC2)CCCCN3C(=O)[C@H]4[C@@H]5CC[C@@H](C5)[C@H]4C3=O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.